Nello Mainolfi is the founder of Kymera Therapeutics. Kymera Therapeutics has raised $3B in total funding. Latest round: Series C.
Nello Mainolfi is the Founder, President, and Chief Executive Officer of Kymera Therapeutics, a biotechnology company focused on targeted protein degradation to develop new medicines. Under his leadership, Kymera has advanced multiple clinical-stage degrader programs, built a drug discovery platform, and raised close to $3 billion in capital. Prior to Kymera, Nello led teams at Novartis that identified several novel investigational medicines, including the first-in-class, FDA-approved factor B inhibitor iptacopan.
Full founder directory · Investor directory · Company funding database · Fundraising library